{
    "Trade/Device Name(s)": [
        "Factor VIII Antibody Screen"
    ],
    "Submitter Information": "Genetic Testing Institute, Inc. (GTI)",
    "510(k) Number": "K082205",
    "Predicate Device Reference 510(k) Number(s)": [
        "K993553"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GGP"
    ],
    "Summary Letter Date": "October 20, 2008",
    "Summary Letter Received Date": "October 23, 2008",
    "Submission Date": "June 24, 2008",
    "Regulation Number(s)": [
        "21 CFR 864.7290"
    ],
    "Regulation Name(s)": [
        "Factor Deficiency Test"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "immunology"
    ],
    "Analyte(s)": [
        "IgG antibodies reactive with recombinant human Factor VIII"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "ACD tube",
        "Sodium citrate tube",
        "Serum tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Spectrophotometer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme Linked Immunosorbent Assay (ELISA)",
        "Colorimetric endpoint"
    ],
    "Methodologies": [
        "Solid phase immunoassay",
        "ELISA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for GTI Factor VIII Antibody Screen ELISA to detect IgG antibodies to recombinant Factor VIII in human serum and plasma",
    "Indications for Use Summary": "Qualitative ELISA kit for screening patient samples for IgG antibodies reactive with human Factor VIII in hemostasis and other laboratories",
    "fda_folder": "Hematology"
}